CClinicalTrials.gg
CompletedNCT04446143Updated Feb 15, 2022

Effects on Mindfulness Meditation on Patient's Satisfaction During Urodynamic Study

An interventional study of Mindfulness meditation in Personal Satisfaction, sponsored by Loma Linda University. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-02-15.

Sponsored by Loma Linda University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The purpose of this investigator-initiated study is to evaluate if mindfulness-based stress reduction (MBSR) will improve satisfaction and reduce anxiety during a urodynamic study (UDS).

Read the detailed description

Urodynamic studies (UDS) are used to measure the functionality of the bladder and urethra to be able to evaluate lower urinary tract symptoms (LUTS). UDS consists of catheterization, uroflow and cystometrogram. Intravesical, vaginal or rectal transducer placements, and placement of perineal electrodes are part of the study protocol. During the study the bladder will be filled slowly with sterile fluid and the patient will be asked about sensation of filling. At the end of the study the patient will be asked to void.

Although beneficial for diagnosis of underlying LUTS, UDS maybe associated with heightened patient anxiety and feeling of discomfort. In a recently published pilot study, it was shown that a mindfulness-based stress reduction (MBSR) protocol may help improve a patient's emotional health and perception of UDS. To validate the findings from this previous study, the current study aims to implement a MBSR protocol in a randomized prospective study. Patients scheduled for UDS will be randomized into two groups. One group will listen to mindfulness meditation prior to the UDS and the other group won't.

All patients will complete validated questionnaires to assess their satisfaction, anxiety and pain level as well as lower urinary tract symptoms before and after intervention.

02

Conditions studied

  • Personal Satisfaction

Keywords

  • meditation, urodynamics, satisfaction, pain, anxiety
03

In context

Lead sponsor

Loma Linda University is the lead sponsor of 297 studies on the registry; 48 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 23 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female and male patients between ages 18 and 99 with clinical indication for UDS ordered by treating physician

Exclusion criteria

Exclusion Criteria:

  • None English speakers will be recruited for this study.
  • Pregnancy
  • Prioners
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Other
    Application of mindfulness meditation prior to UDS

    Those in the mindfulness medication group will listen to an audio-taped mediation, which takes 10 mins to complete.

    Behavioral: Mindfulness meditation

  • Active comparator
    No meditation prior to UDS

    The control group will be seated in a quiet empty room where they wait for 10 min.

    Behavioral: Mindfulness meditation

Interventions

  • BehavioralMindfulness meditation

    Mindfulness meditation

06

What researchers measure

Primary outcomes

  1. Satisfaction during the urodynamic study testing

    Likert scale will measure satisfaction with urodynamics in both groups. The scale ranges are: very dissatisfied=0, dissatisfied=1, somehow satisfied=2, satisfied=3, very satisfied=4), with 0 as the worse outcome.

    Time frame: 1 year

Secondary outcomes

  1. Self evaluation of anxiety and comfort level

    The State-Trait Anxiety Inventory (STAI 6) score will be obtained before and after the study. It measures stress and anxiety. It ranges from: not al all=1, somewhat=2, moderately so=3, very much so=4), with 4 as the worse outcome.

    Time frame: 1 year

  2. Pain level

    The visualised analog pain score (VAS) will be obtained before and after the study. It measure the degree of pain and a range between 0-10 (0=no pain et all and 10=worst pain ever), with 10 as the worse outcome.

    Time frame: 1 year

07

Study locations

1 site
  • Loma Linda University Faculty Medical Offices
    Loma Linda, California 92354, United States
08

References and documents

Publications

  • Uberoi P, Smitherman A, Aden J, Park G, Jellison F. Incorporation of Mindfulness Exercises to Reduce Anxiety During Urodynamic Testing: A Randomized Single-Blind Controlled Pilot Trial. J Altern Complement Med. 2020 Jan;26(1):74-75. doi: 10.1089/acm.2018.0447. Epub 2019 Sep 25. No abstract available. PubMed 31553223 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04446143
Lead sponsor
Loma Linda University
Responsible party
Sponsor
First posted
Jun 24, 2020
Start date
Dec 1, 2020
Primary completion
Jul 15, 2021
Completion
Jul 15, 2021
Last update
Feb 15, 2022

Study contacts

Andrea Staack
principal investigator · Loma Linda Univ Health

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion